Condylox (PODOFILOX)
Condylox (PODOFILOX) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Condylox; Generic name: PODOFILOX; Manufacturer: Allergan, Inc..
| Brand name | Condylox |
|---|---|
| Generic name | PODOFILOX |
| Manufacturer | Allergan, Inc. |
| Used for | INDICATIONS AND USAGE Condylox Gel 0.5% is indicated for the topical treatment of anogenital warts (external genital warts and perianal warts). This product is not indicated in the treatment of mucous membrane warts (see PRECAUTIONS ). Diagnosis Although anogenital warts have a characteristic appearance, histopathologic confirmation should be obtained if there is any doubt of the diagnosis. Differentiating warts from squamous cell carcinoma and "Bowenoid papulosis" is of particular concern. Squamous cell carcinoma may also be associated with human papillomavirus which should not be treated with Condylox Gel 0.5%. |
| Dosage | DOSAGE AND ADMINISTRATION The prescriber should ensure that the patient is fully aware of the correct method of therapy and identify which specific warts should be treated. Apply twice daily for 3 consecutive days, then discontinue for 4 consecutive days. This one-week cycle of treatment may be repeated until there is no visible wart tissue or for a maximum of four cycles. If there is incomplete response after four treatment cycles, discontinue treatment and consider alternative treatment. Safet |
| Warnings | WARNINGS Correct diagnosis of the lesions to be treated is essential. See the Diagnosis subsection of the INDICATIONS AND USAGE section. Condylox Gel 0.5% is intended for cutaneous use only. Avoid contact with the eyes. If contact with the eyes occurs, patients should immediately flush the eyes with copious quantities of water and seek medical advice. Drug Product is Flammable. Keep Away f rom Open Flame. |
| Active ingredient(s) | PODOFILOX |
| Route | TOPICAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=032e4bcb-b1ed-4029-b2a6-e92f3bf5cc37 |